Helen Sabzevari
CIK 1724195 · President and CEO · last filed 2026-06-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$16.77M
Companies
3
Total Filings
52
Lifetime Open-Market Net
-$4.85M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PGEN | President and CEO | 3,768,872 | $4.45 | $16.77M | -$4.49M | 35 | 2026-06-01 |
| Kinnate Biopharma Inc. (KNTE) Delisted | Director | — | $2.65 | — | $0 | 3 | 2023-06-13 |
| PRECIGEN, INC. (XON) Delisted | President and CEO | 104,734 | — | — | -$366.3K | 13 | 2020-01-07 |
Recent Filings · Page 5 of 6
52 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-01-06 | PRECIGEN, INC. (XON) Delisted | Mixed | +5,880 | -$22.4K | EDGAR |
| 2020-01-03 | PRECIGEN, INC. (XON) Delisted | Mixed | +9,510 | -$27.0K | EDGAR |
| 2019-10-02 | PRECIGEN, INC. (XON) Delisted | Mixed | +9,336 | -$27.5K | EDGAR |
| 2019-07-19 | PRECIGEN, INC. (XON) Delisted | Mixed | +16,516 | -$63.4K | EDGAR |
| 2019-07-02 | PRECIGEN, INC. (XON) Delisted | Mixed | +9,519 | -$37.4K | EDGAR |
| 2019-04-11 | PRECIGEN, INC. (XON) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-29 | PRECIGEN, INC. (XON) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-08 | PRECIGEN, INC. (XON) Delisted | Grant (A) | +13,774 | $0 | EDGAR |
| 2019-01-04 | PRECIGEN, INC. (XON) Delisted | Mixed | +5,934 | -$27.1K | EDGAR |
| 2018-07-19 | PRECIGEN, INC. (XON) Delisted | Mixed | +16,598 | -$122.2K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.